The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations
Crossref DOI link: https://doi.org/10.1007/s12471-016-0905-8
Published Online: 2016-10-04
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
den Hartog, A. W.
Franken, R.
van den Berg, M. P.
Zwinderman, A. H.
Timmermans, J.
Scholte, A. J.
de Waard, V.
Spijkerboer, A. M.
Pals, G.
Mulder, B. J. M.
Groenink, M.
License valid from 2016-10-04